The retinoblastoma gene product activates transcription of the hepatitis B virus pregenomic promoter through the Sp1 binding sites

Journal of General Virology

Volumn 77, Issue 11, 1996, Pages 2775-2780

  Park, Geon Tae ^a   Choi, Cheol Yong ^a   Rho, Hyune Mo ^a  

^a Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR SP1;

ARTICLE; BINDING SITE; CELL STRAIN HEPG2; CONTROLLED STUDY; ENHANCER REGION; EXPRESSION VECTOR; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TUMOR SUPPRESSOR GENE; VIRUS TRANSCRIPTION;

HEPATITIS B VIRUS;

EID: 0029819065     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-77-11-2775     Document Type: Article

References (24)

1. Cattaneo, R., H. Will, H. & Schaller, H. (1984). Hepatitis B virus transcription in the infected liver. EMBO Journal 3, 2191-2196.
2. Chen, I.-H., Huang, C.-J. & Ting, L.-P. (1995). Overlapping initiator and TATA box functions in the basal core promoter of hepatitis B virus. Journal of Virology 69, 3647-3657.
3. DeCaprio, J. A., Furukawa, Y., Ajchenbaum, F., Griffin, J. D. & Livingston, D. M. (1992). The retinoblastoma-susceptibility gene product becomes phosphorylated in multiple stages during cell cycle entry and progression. Proceedings of the National Academy of Sciences, USA 89, 1795-1798.
4. Gu, W., Schneider, J. W., Condorell, G., Kaushal, S., Mahdavl, V. & Nadal-Ginard, V. (1993). Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 72, 309-324.
5. Hiebert, S. W., Chellappan, S. P., Horowitz, J. M. & Nevins, J. R. (1992). The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes & Development 6, 177-185.
6. Johnson, J. L., Raney, A. K. & McLachlan, A. (1995). Characterization of a functional hepatocyte nuclear factor 3 binding site in the hepatitis B virus nucleocapsid promoter. Virology 208, 147-158.
7. Kim, S. H., Hong, S. P., Kim, S. K., Lee, W. S. & Rho, H. M. (1992a). Replication of a mutant hepatitis B virus with a fused X-C reading frame in hepatoma cells. Journal of General Virology 73, 2421-2424.
8. Kim, S.-J., Wagner, S., Liu, F., O'Reilly, M. A., Robbins, P. D. & Green, M. R. (1992b). Retinoblastoma gene product activates expression of the human TGF-β2 gene through transcription factor ATF-2. Nature 358, 331-334.
9. Kim, S.-J., Onwuta, U. S., Lee, Y. I., Li, R., Botchan, M. R. & Robbins, P. D. (1992c). The retinoblastoma gene product regulates Sp-1 mediated transcription. Molecular and Cellular Biology 12, 2455-2463.
10. Kim, S. K., Jang, S. K. & Rho, H. M. (1994). Effect of frameshift mutation in the pre-C region of hepatitis B virus on the X and C genes. Journal of General Virology 75, 917-923.
11. Leggett, R. W. & Mueller, C. R. (1994). Retinoblastoma control element binding proteins are induced during in vivo terminal differentiation of the liver and bind to the DBP promoter. DNA and Cell Biology 13, 693-703.
12. Lopez-Cabrera, M., Letovsky, J., Hu, K.-Q. & Siddiqui, A. (1991). Transcriptional factor C/EBP binds to and transactivates the enhancer element II of the hepatitis B virus. Virology 183, 825-829.
13. Reith, W., Ucla, C., Barras, E., Gaud, A., Durand, B., Herrero-Sanchez, C., Kobr, M. & Mach, B. (1994). RFX1, a transactivator of hepatitis B virus enhancer I, belongs to a novel family of homodimeric and heterodimeric DNA-binding proteins. Molecular and Cellular Biology 14, 1230-1244.
14. Rho, H. M., Kim, K. T., Hyun, S. W. & Kim, Y. S. (1989). The nucleotide sequence and reading frames of a mutant hepatitis B virus subtype adr. Nucleic Acids Research 17, 2124.
15. Robbins, P. D., Horowitz, J. M. & Mulligan, R. C. (1990). Negative regulation of human c-fos expression by the retinoblastoma gene product. Nature 346, 668-671.
16. Seeger, C., D. Ganem, D. & Varmus, H. E. (1986). Biochemical and genetic evidence for the hepatitis B virus replication strategy. Science 232, 477-484.
17. Shim, J. W., Choi, C, Y., Park, G. T. & Rho, H. M. (1993). Purification and characterization of the mutant hepatitis B viral elongated X gene product expressed in Escherichia coli. Korean Biochemical Journal 26, 396-401.
18. Su, H. & Yee, J.-K. (1992). Regulation of hepatitis B virus gene expression by its two enhancers. Proceedings of the National Academy of Sciences, USA 89, 2708-2712.
19. Sureau, C., Romet-Lemonne, J.-L., Mullins, J. I. & Essex, M. (1986). Production of hepatitis B virus by a differentiated human hepatoma cell line after transfection with cloned circular HBV DNA. Cell 47, 37-47.
20. Twu, J. S., Lai, M. Y., Chen, D. S. & Robinson, W. S. (1993). Activation of protooncogene c-jun by the X protein of hepatitis B virus. Virology 192, 346-350.
21. Udvadia, A. J., Rogers, K. T., Higgins, P. D. R., Murata, Y., Martin, K. H., Humphrey, P. A. & Horowitz, J. M. (1993). Sp-1 binds promoter elements regulated by the RB protein and Sp-1 mediated transcription is stimulated by RB coexpression. Proceedings of the National Academy of Sciences, USA 90, 3265-3269.
22. Udvadia, A. J., Templeton, D. J. & Horowitz, J. M. (1995). Functional interactions between the retinoblastoma (Rb) protein and Sp-family members: superactivation by Rb requires amino acids necessary for growth suppression. Proceedings of the National Academy of Sciences, USA 92, 3953-3957.
23. Weinberg, R. A. (1989). Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. Cancer Research 49, 3713-3721.
24. Zhang, P., Raney, A. K. & McLachlan, A. (1993). Characterization of functional Sp1 transcription factor binding sites in the hepatitis B virus nucleocapsid promoter. Journal of Virology 67, 1472-1481.